Larry Todd Edwards, the See Remarks of $ARQT, sold 297 shares of the company on 10-02-2025 for an estimated $6,171. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.2% of their shares of this class of stock. Following this trade, they now own 179,324 shares of this class of $ARQT stock.
$ARQT Insider Trading Activity
$ARQT insiders have traded $ARQT stock on the open market 37 times in the past 6 months. Of those trades, 6 have been purchases and 31 have been sales.
Here’s a breakdown of recent trading of $ARQT stock by insiders over the last 6 months:
- TODD WATANABE (See Remarks) has made 0 purchases and 7 sales selling 78,124 shares for an estimated $1,401,623.
- HOWARD G. WELGUS has made 0 purchases and 8 sales selling 59,347 shares for an estimated $897,953.
- MASARU MATSUDA (See Remarks) has made 0 purchases and 4 sales selling 49,290 shares for an estimated $775,663.
- PATRICK BURNETT (See Remarks) has made 0 purchases and 8 sales selling 45,875 shares for an estimated $682,568.
- PATRICK J HERON has made 6 purchases buying 19,888 shares for an estimated $269,900 and 0 sales.
- LARRY TODD EDWARDS (See Remarks) has made 0 purchases and 3 sales selling 11,955 shares for an estimated $195,113.
- LATHA VAIRAVAN (SVP Chief Financial Officer) sold 89 shares for an estimated $1,275
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ARQT Hedge Fund Activity
We have seen 120 institutional investors add shares of $ARQT stock to their portfolio, and 109 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANUS HENDERSON GROUP PLC added 2,211,360 shares (+4204.1%) to their portfolio in Q2 2025, for an estimated $31,003,267
- POLAR CAPITAL HOLDINGS PLC removed 1,700,000 shares (-25.3%) from their portfolio in Q2 2025, for an estimated $23,834,000
- PARADIGM BIOCAPITAL ADVISORS LP removed 1,465,334 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $20,543,982
- INVESCO LTD. removed 1,229,251 shares (-92.5%) from their portfolio in Q2 2025, for an estimated $17,234,099
- FRAZIER LIFE SCIENCES MANAGEMENT, L.P. added 1,089,227 shares (+12.4%) to their portfolio in Q2 2025, for an estimated $15,270,962
- CERCANO MANAGEMENT LLC removed 928,701 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $13,020,388
- PFM HEALTH SCIENCES, LP added 923,375 shares (+inf%) to their portfolio in Q2 2025, for an estimated $12,945,717
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ARQT Analyst Ratings
Wall Street analysts have issued reports on $ARQT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 08/07/2025
To track analyst ratings and price targets for $ARQT, check out Quiver Quantitative's $ARQT forecast page.
$ARQT Price Targets
Multiple analysts have issued price targets for $ARQT recently. We have seen 2 analysts offer price targets for $ARQT in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- Serge Belanger from Needham set a target price of $22.0 on 08/07/2025
- Richard Law from Goldman Sachs set a target price of $18.0 on 07/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
